Cardlytics (CDLX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CDLX Stock Forecast

Cardlytics stock forecast is as follows: an average price target of $6.70 (represents a 86.11% upside from CDLX’s last price of $3.60) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

CDLX Price Target

The average price target for Cardlytics (CDLX) is $6.70 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $17.00 to $3.50. This represents a potential 86.11% upside from CDLX's last price of $3.60.

CDLX Analyst Ratings

Buy

According to 4 Wall Street analysts, Cardlytics's rating consensus is 'Buy'. The analyst rating breakdown for CDLX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 1 'Hold' (25.00%), 1 'Sell' (25.00%), and 0 'Strong Sell' (0.00%).

Cardlytics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 11, 2024	Mark Mahaney	Evercore ISI	$4.00	$3.22	24.22%	11.11%
Aug 16, 2024	Luke Horton	Northland Securities	$5.00	$3.75	33.33%	38.89%
Aug 15, 2024	Omar Dessouky	Bank of America Securities	$3.50	$3.69	-5.15%	-2.78%
Aug 08, 2024	Jason Kreyer	Craig-Hallum	$4.00	$2.96	35.14%	11.11%
Aug 08, 2024	Luke Horton	Northland Securities	$7.00	$6.90	1.45%	94.44%
Jun 18, 2024	Luke Horton	Northland Securities	$14.00	$8.21	70.63%	288.89%
Apr 09, 2024	Kyle Peterson	Needham	$17.00	$14.01	21.34%	372.22%
Aug 02, 2023	Kyle Peterson	Needham	$19.00	$13.48	40.95%	427.78%
Nov 02, 2022	Kyle Peterson	Needham	$14.00	$5.70	145.61%	288.89%
May 03, 2022	Jason Kreyer	Craig-Hallum	$50.00	$35.86	39.43%	1288.89%

Row per page

Go to

The latest Cardlytics stock forecast, released on Oct 11, 2024 by Mark Mahaney from Evercore ISI, set a price target of $4.00, which represents a 24.22% increase from the stock price at the time of the forecast ($3.22), and a 11.11% increase from CDLX last price ($3.60).

Cardlytics Price Target by Period

	1M	3M	12M
# Anlaysts	-	3	7
Avg Price Target	-	$4.17	$7.79
Last Closing Price	$3.60	$3.60	$3.60
Upside/Downside	-100.00%	15.83%	116.39%

In the current month, the average price target of Cardlytics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cardlytics's last price of $3.60. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 15, 2024	Northland Securities	Buy	Buy	Hold
Aug 08, 2024	Needham	Buy	Positive	Downgrade
Aug 08, 2024	Craig-Hallum	Buy	Hold	Downgrade
Jun 11, 2024	Lake Street	Underperform	Underperform	Hold
Jun 11, 2024	Needham	Buy	Buy	Hold
Apr 09, 2024	Lake Street	Underperform	Underperform	Hold
Apr 09, 2024	Needham	Buy	Buy	Hold
Mar 15, 2024	Needham	Buy	Buy	Hold
Mar 15, 2024	Craig-Hallum	-	Buy	Upgrade
Aug 02, 2023	Needham	Buy	Buy	Hold

Row per page

Go to

Cardlytics's last stock rating was published by Northland Securities on Aug 15, 2024. The company gave CDLX a "Buy" rating, the same as its previous rate.

Cardlytics Financial Forecast

Cardlytics Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18
Revenue	-	-	-	-	-	-	-	-	$89.17M	$79.00M	$143.33M	$67.93M	$82.50M	$72.71M	$75.41M	$67.93M	$90.05M	$64.98M	$58.85M	$53.23M	$67.08M	$46.08M	$28.22M	$45.51M	$69.29M	$56.42M	$48.73M	$35.99M	$32.71M
Avg Forecast	$76.40M	$73.28M	$67.94M	$61.87M	$64.29M	$57.77M	$75.39M	$71.69M	$89.55M	$80.05M	$69.11M	$65.06M	$83.58M	$73.90M	$76.05M	$64.66M	$76.53M	$62.09M	$62.87M	$51.07M	$60.89M	$38.82M	$30.78M	$42.96M	$64.63M	$49.99M	$44.06M	$36.13M	$57.95M
High Forecast	$78.99M	$75.76M	$70.24M	$63.97M	$66.47M	$57.78M	$75.39M	$74.12M	$89.63M	$82.76M	$71.45M	$67.27M	$86.41M	$73.90M	$76.05M	$64.66M	$76.53M	$62.09M	$62.87M	$51.07M	$60.89M	$38.82M	$30.78M	$42.96M	$64.63M	$49.99M	$44.06M	$36.13M	$69.54M
Low Forecast	$72.21M	$69.26M	$64.21M	$58.47M	$60.76M	$57.77M	$75.39M	$67.75M	$89.50M	$75.65M	$65.32M	$61.49M	$78.99M	$73.90M	$76.05M	$64.66M	$76.53M	$62.09M	$62.87M	$51.07M	$60.89M	$38.82M	$30.78M	$42.96M	$64.63M	$49.99M	$44.06M	$36.13M	$46.36M
# Analysts	1	1	1	2	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	8	8	9	12	7	7	8	16
Surprise %	-	-	-	-	-	-	-	-	1.00%	0.99%	2.07%	1.04%	0.99%	0.98%	0.99%	1.05%	1.18%	1.05%	0.94%	1.04%	1.10%	1.19%	0.92%	1.06%	1.07%	1.13%	1.11%	1.00%	0.56%

Cardlytics's average Quarter revenue forecast for Mar 24 based on 1 analysts is $71.69M, with a low forecast of $67.75M, and a high forecast of $74.12M. CDLX's average Quarter revenue forecast represents a -19.60% decrease compared to the company's last Quarter revenue of $89.17M (Dec 23).

Cardlytics EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18
# Analysts	1	1	1	2	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	8	8	9	12	7	7	8	16
EBITDA	-	-	-	-	-	-	-	-	$6.70M	$-14.66M	$-16.88M	$-24.07M	$-18.28M	$-24.30M	$-28.04M	$-22.56M	$-1.39M	$-31.49M	$-34.01M	$-17.62M	$-976.00K	$-12.20M	$-17.32M	$-10.28M	$4.82M	$-6.20M	$-4.99M	$-4.86M	$-19.14M
Avg Forecast	$-29.48M	$-28.27M	$-26.21M	$-23.87M	$-24.80M	$-22.29M	$-29.09M	$-27.66M	$-34.55M	$-30.88M	$-26.66M	$-25.10M	$-32.25M	$-13.81M	$-14.21M	$59.46M	$-14.30M	$-11.60M	$-11.75M	$-17.62M	$-11.38M	$-7.25M	$-5.75M	$-7.83M	$-12.08M	$-9.34M	$-8.23M	$-6.62M	$-24.73M
High Forecast	$-27.86M	$-26.72M	$-24.77M	$-22.56M	$-23.44M	$-22.29M	$-29.09M	$-26.14M	$-34.53M	$-29.19M	$-25.20M	$-23.72M	$-30.48M	$-13.81M	$-14.21M	$71.35M	$-14.30M	$-11.60M	$-11.75M	$-14.10M	$-11.38M	$-7.25M	$-5.75M	$-6.27M	$-12.08M	$-9.34M	$-8.23M	$-5.30M	$-19.79M
Low Forecast	$-30.47M	$-29.23M	$-27.10M	$-24.68M	$-25.64M	$-22.29M	$-29.09M	$-28.60M	$-34.58M	$-31.93M	$-27.57M	$-25.95M	$-33.34M	$-13.81M	$-14.21M	$47.57M	$-14.30M	$-11.60M	$-11.75M	$-21.15M	$-11.38M	$-7.25M	$-5.75M	$-9.40M	$-12.08M	$-9.34M	$-8.23M	$-7.94M	$-29.68M
Surprise %	-	-	-	-	-	-	-	-	-0.19%	0.47%	0.63%	0.96%	0.57%	1.76%	1.97%	-0.38%	0.10%	2.71%	2.89%	1.00%	0.09%	1.68%	3.01%	1.31%	-0.40%	0.66%	0.61%	0.73%	0.77%

1 analysts predict CDLX's average Quarter EBITDA for Mar 24 to be $-27.66M, with a high of $-26.14M and a low of $-28.60M. This is -513.13% lower than Cardlytics's previous annual EBITDA (Dec 23) of $6.70M.

Cardlytics Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18
# Analysts	1	1	1	2	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	8	8	9	12	7	7	8	16
Net Income	-	-	-	-	-	-	-	-	$-100.84M	$-23.97M	$-93.25M	$33.04M	$-371.86M	$49.59M	$-126.29M	$101.02M	$-27.56M	$-44.53M	$-47.31M	$-24.89M	$-6.78M	$-15.36M	$-19.76M	$-13.53M	$3.43M	$-7.75M	$-6.51M	$-6.31M	$-20.05M
Avg Forecast	$-15.51M	$-17.18M	$-19.51M	$-22.01M	$-23.51M	$-28.35M	$-23.01M	$-21.51M	$-11.51M	$-32.52M	$-36.52M	$-39.53M	$-40.21M	$-48.27M	$-43.05M	$43.25M	$-40.10M	$-46.73M	$-32.08M	$-24.89M	$-19.20M	$-29.52M	$-27.82M	$-10.31M	$-8.97M	$-14.02M	$-18.57M	$-8.59M	$-25.91M
High Forecast	$-14.40M	$-15.95M	$-18.12M	$-20.44M	$-21.83M	$-26.32M	$-21.37M	$-19.98M	$-2.88M	$-30.20M	$-33.91M	$-36.71M	$-37.33M	$-48.27M	$-43.05M	$51.90M	$-40.10M	$-46.73M	$-32.08M	$-19.92M	$-19.20M	$-29.52M	$-27.82M	$-8.25M	$-8.97M	$-14.02M	$-18.57M	$-6.88M	$-20.73M
Low Forecast	$-16.19M	$-17.93M	$-20.37M	$-22.98M	$-24.55M	$-29.60M	$-24.03M	$-22.46M	$-23.97M	$-33.95M	$-38.13M	$-41.27M	$-41.97M	$-48.27M	$-43.05M	$34.60M	$-40.10M	$-46.73M	$-32.08M	$-29.87M	$-19.20M	$-29.52M	$-27.82M	$-12.37M	$-8.97M	$-14.02M	$-18.57M	$-10.31M	$-31.09M
Surprise %	-	-	-	-	-	-	-	-	8.76%	0.74%	2.55%	-0.84%	9.25%	-1.03%	2.93%	2.34%	0.69%	0.95%	1.47%	1.00%	0.35%	0.52%	0.71%	1.31%	-0.38%	0.55%	0.35%	0.73%	0.77%

Cardlytics's average Quarter net income forecast for Jun 23 is $-36.52M, with a range of $-38.13M to $-33.91M. CDLX's average Quarter net income forecast represents a -210.54% decrease compared to the company's last Quarter net income of $33.04M (Mar 23).

Cardlytics SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18
# Analysts	1	1	1	2	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	8	8	9	12	7	7	8	16
SG&A	-	-	-	-	-	-	-	-	$14.11M	$14.16M	$15.21M	$38.07M	$36.89M	$38.26M	$42.97M	$38.07M	$36.08M	$36.81M	$33.95M	$25.38M	$23.80M	$24.19M	$22.14M	$21.71M	$21.53M	$23.29M	$19.39M	$16.34M	$14.80M
Avg Forecast	$34.66M	$33.24M	$30.82M	$28.07M	$29.17M	$26.21M	$34.20M	$32.52M	$40.63M	$36.32M	$31.35M	$29.52M	$37.92M	$34.87M	$35.89M	$49.84M	$36.11M	$29.30M	$29.67M	$25.38M	$28.74M	$18.32M	$14.53M	$16.54M	$30.50M	$23.59M	$20.79M	$22.24M	$19.12M
High Forecast	$35.83M	$34.37M	$31.87M	$29.02M	$30.15M	$26.21M	$34.20M	$33.63M	$40.66M	$37.55M	$32.42M	$30.52M	$39.20M	$34.87M	$35.89M	$59.81M	$36.11M	$29.30M	$29.67M	$30.45M	$28.74M	$18.32M	$14.53M	$19.85M	$30.50M	$23.59M	$20.79M	$26.68M	$22.94M
Low Forecast	$32.76M	$31.42M	$29.13M	$26.53M	$27.56M	$26.21M	$34.20M	$30.74M	$40.60M	$34.32M	$29.63M	$27.89M	$35.84M	$34.87M	$35.89M	$39.87M	$36.11M	$29.30M	$29.67M	$20.30M	$28.74M	$18.32M	$14.53M	$13.23M	$30.50M	$23.59M	$20.79M	$17.79M	$15.29M
Surprise %	-	-	-	-	-	-	-	-	0.35%	0.39%	0.48%	1.29%	0.97%	1.10%	1.20%	0.76%	1.00%	1.26%	1.14%	1.00%	0.83%	1.32%	1.52%	1.31%	0.71%	0.99%	0.93%	0.73%	0.77%

Cardlytics's average Quarter SG&A projection for Mar 24 is $32.52M, based on 1 Wall Street analysts, with a range of $30.74M to $33.63M. The forecast indicates a 130.49% rise compared to CDLX last annual SG&A of $14.11M (Dec 23).

Cardlytics EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18
# Analysts	1	1	1	2	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	8	8	9	12	7	7	8	16
EPS	-	-	-	-	-	-	-	-	$-2.56	$-0.63	$-2.67	$1.02	$-11.13	$1.50	$-3.75	$2.99	$-0.83	$-1.35	$-1.43	$-0.85	$-0.24	$-0.56	$-0.73	$-0.51	$0.13	$-0.33	$-0.29	$-0.28	$-1.54
Avg Forecast	$-0.31	$-0.34	$-0.39	$-0.44	$-0.47	$-0.57	$-0.46	$-0.43	$-0.23	$-0.65	$-0.73	$-0.79	$-0.80	$-0.98	$-0.88	$-0.92	$-0.82	$-0.95	$-0.65	$-0.58	$-0.39	$-0.60	$-0.57	$-0.37	$-0.18	$-0.29	$-0.38	$-0.59	$-0.80
High Forecast	$-0.29	$-0.32	$-0.36	$-0.41	$-0.44	$-0.53	$-0.43	$-0.40	$-0.06	$-0.60	$-0.68	$-0.73	$-0.75	$-0.98	$-0.88	$-0.92	$-0.82	$-0.95	$-0.65	$-0.58	$-0.39	$-0.60	$-0.57	$-0.37	$-0.18	$-0.29	$-0.38	$-0.59	$-0.64
Low Forecast	$-0.32	$-0.36	$-0.41	$-0.46	$-0.49	$-0.59	$-0.48	$-0.45	$-0.48	$-0.68	$-0.76	$-0.83	$-0.84	$-0.98	$-0.88	$-0.92	$-0.82	$-0.95	$-0.65	$-0.58	$-0.39	$-0.60	$-0.57	$-0.37	$-0.18	$-0.29	$-0.38	$-0.59	$-0.96
Surprise %	-	-	-	-	-	-	-	-	11.13%	0.97%	3.66%	-1.29%	13.85%	-1.52%	4.27%	-3.26%	1.02%	1.42%	2.19%	1.47%	0.61%	0.93%	1.29%	1.39%	-0.71%	1.16%	0.77%	0.47%	1.93%

According to 1 Wall Street analysts, Cardlytics's projected average Quarter EPS for Jun 23 is $-0.73, with a low estimate of $-0.76 and a high estimate of $-0.68. This represents a -171.57% decrease compared to CDLX previous annual EPS of $1.02 (Mar 23).

Cardlytics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
TRMR	Nexxen	$5.02	$17.00	238.65%	Buy
CDLX	Cardlytics	$3.60	$6.70	86.11%	Buy
ADV	Advantage Solutions	$3.24	$6.00	85.19%	Hold
EEX	Emerald	$4.60	$7.90	71.74%	Buy
IPG	Interpublic Group of Companies	$29.20	$47.33	62.09%	Buy
CMPR	Cimpress	$80.48	$120.00	49.11%	-
IAS	Integral Ad Science	$10.77	$15.78	46.52%	Buy
CTV	Innovid	$1.72	$2.50	45.35%	Buy
CRTO	Criteo	$37.92	$49.56	30.70%	Buy
QNST	QuinStreet	$20.82	$25.63	23.10%	Buy
DLX	Deluxe	$23.34	$27.00	15.68%	Buy
BOC	Boston Omaha	$14.70	$17.00	15.65%	Buy
OMC	Omnicom Group	$105.04	$118.17	12.50%	Buy

CDLX Forecast FAQ

Is Cardlytics a good buy?

Yes, according to 4 Wall Street analysts, Cardlytics (CDLX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 50.00% of CDLX's total ratings.

What is CDLX's price target?

Cardlytics (CDLX) average price target is $6.7 with a range of $3.5 to $17, implying a 86.11% from its last price of $3.6. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cardlytics stock go up soon?

According to Wall Street analysts' prediction for CDLX stock, the company can go up by 86.11% (from the last price of $3.6 to the average price target of $6.7), up by 372.22% based on the highest stock price target, and down by -2.78% based on the lowest stock price target.

Can Cardlytics stock reach $5?

CDLX's average twelve months analyst stock price target of $6.7 supports the claim that Cardlytics can reach $5 in the near future.

What are Cardlytics's analysts' financial forecasts?

Cardlytics's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $269.15M (high $273.76M, low $261.68M), average EBITDA is $-104M (high $-101M, low $-106M), average net income is $-96.387M (high $-89.504M, low $-101M), average SG&A $122.1M (high $124.19M, low $118.71M), and average EPS is $-1.927 (high $-1.789, low $-2.011). CDLX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $279.5M (high $288.96M, low $264.14M), average EBITDA is $-108M (high $-102M, low $-111M), average net income is $-74.208M (high $-68.909M, low $-77.475M), average SG&A $126.8M (high $131.09M, low $119.83M), and average EPS is $-1.483 (high $-1.377, low $-1.549).

Did the CDLX's actual financial results beat the analysts' financial forecasts?

Based on Cardlytics's last annual report (Dec 2023), the company's revenue was $309.2M, beating the average analysts forecast of $303.78M by 1.79%. Apple's EBITDA was $26.46M, missing the average prediction of $-117M by -122.58%. The company's net income was $-135M, beating the average estimation of $-120M by 12.18%. Apple's SG&A was $57.42M, missing the average forecast of $137.81M by -58.33%. Lastly, the company's EPS was $-3.69, beating the average prediction of $-2.4 by 53.74%. In terms of the last quarterly report (Dec 2023), Cardlytics's revenue was $89.17M, missing the average analysts' forecast of $89.55M by -0.43%. The company's EBITDA was $6.7M, missing the average prediction of $-34.548M by -119.38%. Cardlytics's net income was $-101M, beating the average estimation of $-11.506M by 776.36%. The company's SG&A was $14.11M, missing the average forecast of $40.63M by -65.27%. Lastly, the company's EPS was $-2.56, beating the average prediction of $-0.23 by 1013.04%